Literature DB >> 1971002

Modulation of growth hormone (GH) secretion and GH mRNA levels by GH-releasing factor, somatostatin and secretagogues in cultured bovine adenohypophysial cells.

J W Tanner1, S K Davis, N H McArthur, J T French, T H Welsh.   

Abstract

The effects of endogenous hypothalamic neurohormones and activators of second messenger signalling systems on the secretion of GH and on cell content of GH mRNA of cultured bovine adenohypophysial cells were studied. Synthetic bovine GH-releasing factor (bGRF; 100 nmol/l) increased secretion of GH by bovine adenohypophysial cells five-fold relative to control. Forskolin (an adenyl cyclase activator; 10 mumol/l) and the synthetic cyclic AMP analogue dibutyryl cyclic AMP (dbcAMP; 1 mmol/l) increased secretion of GH by 1.9- and 1.7-fold respectively, relative to control. The protein kinase C activator phorbol 12-myristate 13-acetate (PMA), provided at 1 mumol/l or 10 nmol/l, increased GH secretion by 6.6- and four-fold respectively, relative to control. Somatostatin-14 (SRIF-14) attenuated basal, bGRF-, forskolin- and dbcAMP-stimulated secretion of GH by 40, 49, 47 and 67% respectively, but did not, however, diminish PMA-stimulated GH secretion. The content of GH mRNA in cultured bovine adenohypophysial cells increased 2.2-, 1.7- and 3.2-fold by administration of bGRF, forskolin and PMA respectively, relative to control. Although GH mRNA content was unchanged by SRIF-14 treatment relative to control, SRIF-14 did reduce bGRF-stimulated bGH mRNA content by 67%. This study demonstrates that mechanisms subserving GH secretion in bovine adenohypophysial cells (e.g. adenyl cyclase and protein kinase C) may be coupled with mechanisms which regulate expression of the GH gene or with factors affecting message stability.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971002     DOI: 10.1677/joe.0.1250109

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

Review 1.  Pituitary somatostatin receptor signaling.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Trends Endocrinol Metab       Date:  2010-02-09       Impact factor: 12.015

2.  Effects of acute administration of growth hormone-releasing hormone (GHRH) and oxytocin on somatotroph cells in sheep: morphometric study and growth hormone (GH) secretion.

Authors:  M Rico; S Vidal; M T Lorenzo; L Moya; L F De la Cruz
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

3.  Constitutive somatostatin receptor subtype 2 activity attenuates GH synthesis.

Authors:  Anat Ben-Shlomo; Oxana Pichurin; Ramtin Khalafi; Cuiqi Zhou; Vera Chesnokova; Song-Guang Ren; Ning-Ai Liu; Shlomo Melmed
Journal:  Endocrinology       Date:  2013-05-21       Impact factor: 4.736

4.  Constitutive somatostatin receptor subtype-3 signaling suppresses growth hormone synthesis.

Authors:  Tamar Eigler; Anat Ben-Shlomo; Cuiqi Zhou; Ramtin Khalafi; Song-Guang Ren; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2014-02-25

Review 5.  Recent advances in neuropeptide-related omics and gene editing: Spotlight on NPY and somatostatin and their roles in growth and food intake of fish.

Authors:  Xiaozheng Yu; Haijun Yan; Wensheng Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-10-04       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.